Bloomage Biotechnology Corp Ltd
SSE:688363
Bloomage Biotechnology Corp Ltd
Cash from Investing Activities
Bloomage Biotechnology Corp Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
Cash from Investing Activities
-¥836.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥2.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥993.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Bloomage Biotechnology Corp Ltd's Cash from Investing Activities?
Cash from Investing Activities
-836.2m
CNY
Based on the financial report for Dec 31, 2022, Bloomage Biotechnology Corp Ltd's Cash from Investing Activities amounts to -836.2m CNY.
What is Bloomage Biotechnology Corp Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-21%
Over the last year, the Cash from Investing Activities growth was 16%. The average annual Cash from Investing Activities growth rates for Bloomage Biotechnology Corp Ltd have been 12% over the past three years , -21% over the past five years .